Evidence map›Paper›PMID 28860766›Full record

ArticleInternational journal of nanomedicine2017

Synthesized zinc peroxide nanoparticles (ZnO

Sameh Samir Ali, Reda Morsy, Nessma Ahmed El-Zawawy, Mervat F Fareed, Mohamed Yaser Bedaiwy

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 137 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Journal of Zhejiang University. Science. B · 2025
    Article
  5. Review of the 100 Most Cited Articles inEuropean burn journal · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Sameh Samir Ali *Biofuels Institute, School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang, China.
Reda Morsy *Physics Department, Faculty of Science, Tanta University, Tanta, Egypt.
Nessma Ahmed El-ZawawyBotany Department, Faculty of Science, Tanta University, Tanta, Egypt.
Mervat F FareedDepartment of Home Economic, Faculty of Specific Education, Tanta University, Tanta, Egypt.
Mohamed Yaser BedaiwyBotany Department, Faculty of Science, Tanta University, Tanta, Egypt.
Tanta University · EGJiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing of multidrug resistance (MDR) remains an intractable challenge for burn patients. Innovative nanomaterials are also in high demand for the development of new antimicrobial biomaterials that inevitably have opened new therapeutic horizons in medical approaches and lead to many efforts for synthesizing new metal oxide nanoparticles (NPs) for better control of the MDR associated with the polymicrobial burn wounds. Recently, it seems that metal oxides can truly be considered as highly efficient inorganic agents with antimicrobial properties. In this study, zinc peroxide NPs (ZnO

Indexed as

AnimalsAnti-Infective AgentsAnti-Inflammatory Agents, Non-SteroidalBurnsCalorimetry, Differential ScanningDrug Resistance, MultipleHumansMetal NanoparticlesMicrobial Sensitivity TestsMicroscopy, Electron, TransmissionPancreatic ElastasePeptide HydrolasesPeroxidesProtease InhibitorsRabbitsSpectroscopy, Fourier Transform InfraredAnti-Infective AgentsAnti-Inflammatory Agents, Non-SteroidalkeratinasePancreatic ElastasePeptide HydrolasesPeroxidesProtease InhibitorsZinc Compoundsanti-inflammatoryantimicrobialburn wound infectionsco-precipitation methodmetal oxides nanoparticlesmultidrug resistance

Identifiers

PMID28860766
PMCPMC5573044
OpenAlexW2745859915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.